Rani Therapeutics Holdings RANI Income Statement (2020-2026)

NASDAQ RANI
$0.57 +0.01 (+1.41%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Rani Therapeutics Holdings Quarterly Income Statement

Periods 26 quarters
Latest Sep 2026

Rani Therapeutics Holdings reported revenue of $1.71M and net income of -$8.81M for the quarter ended Sep 2026. This income statement covers 26 quarters of results from Jun 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
1.03M0.17M1.46M1.71M1.71M1.71M
Operating items
Research & DevelopmentR&D
7.42M7.59M9.53M9.10M10.39M9.71M11.09M11.22M7.61M7.59M6.12M6.17M6.81M6.57M5.51M3.22M4.91M5.16M5.02M6.02M
Selling, General & AdministrativeSG&A
5.95M6.19M6.32M7.24M7.10M6.80M7.21M6.64M5.83M6.45M6.41M5.63M5.46M5.62M5.00M4.04M5.09M4.89M5.52M4.91M
Other Operating ExpensesOther Opex
3.71M
Operating ExpensesOpex
13.36M13.78M15.85M16.34M17.48M16.52M18.29M17.86M13.43M14.03M12.52M11.80M15.99M12.19M10.51M7.26M10.00M10.05M10.54M10.93M
Operating IncomeOp. Inc
-13.36M-13.78M-15.85M-16.34M-17.48M-16.52M-18.29M-17.86M-13.43M-14.03M-12.52M-11.80M-14.96M-12.01M-10.51M-7.26M-8.54M-8.34M-8.83M-9.22M
Non-operating items
Non Operating Interest Expenses
0.00M0.35M0.72M1.21M1.27M1.32M1.30M1.29M1.28M1.34M1.12M0.94M0.88M0.73M0.35M0.09M0.01M0.04M
Interest & Investment IncomeInt & Inv Inc
0.02M0.02M0.04M0.38M0.82M0.89M0.90M0.84M0.68M0.55M0.44M0.41M0.36M0.22M0.16M0.07M0.38M0.41M0.42M0.46M
Other Non Operating IncomeOther Non Op Inc.
1.40M
Net income details
EBIT
-13.36M-13.78M-15.85M-16.34M-17.48M-16.52M-18.29M-17.86M-13.43M-14.03M-12.52M-11.80M-14.96M-12.01M-10.51M-7.26M-8.54M-8.34M-8.83M-9.22M
EBT
-13.35M-13.77M-15.81M-16.32M-17.38M-16.83M-18.66M-18.33M-14.06M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M-8.50M-8.02M-8.42M-8.81M
Tax ProvisionsTaxes
-0.04M0.06M0.15M-0.11M-0.01M
Income After Tax
-13.31M-13.83M-15.97M-16.21M-17.37M-16.83M-18.66M-18.33M-14.06M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M-8.50M-8.02M-8.42M-8.81M
Income from Continuing OperationsIncome (Continuing)
-13.31M-13.83M-15.97M-16.21M-17.37M-16.83M-18.66M-18.33M-14.06M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M-8.50M-8.02M-8.42M-8.81M
Consolidated Net IncomeConsol Net Inc.
-13.31M-13.83M-15.97M-16.21M-17.34M-16.83M-18.66M-18.33M-14.06M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M-9.12M-8.02M-8.42M-8.81M
Net Income Attributable to Noncontrolling InterestsNCI Net Income
-8.12M-7.61M-8.34M-8.25M-8.56M-8.46M-9.36M-9.14M-6.96M-7.30M-6.56M-5.94M-6.78M-5.47M-4.53M-2.50M1.23M-0.98M-1.03M-1.08M
Income towards Parent CompanyParent Net Inc
-5.19M-6.22M-7.62M-7.96M-8.79M-8.37M-9.30M-9.20M-7.10M-7.48M-6.81M-6.78M-8.95M-7.26M-6.69M-5.41M-10.31M-7.03M-7.39M-7.73M
Net Income towards Common StockholdersNet Income
-5.19M-6.22M-7.62M-7.96M-8.79M-8.37M-9.30M-9.20M-7.10M-7.48M-6.81M-6.78M-8.95M-7.26M-6.69M-5.41M-10.31M-7.03M-7.39M-7.73M
Additional items
EPS (Basic)
-0.27-0.29-0.31-0.33-0.37-0.33-0.37-0.36-0.28-0.29-0.26-0.24-0.31-0.22-0.18-0.12-0.16-0.04-0.04-0.04
EPS (Diluted)
-0.27-0.29-0.31-0.33-0.37-0.33-0.37-0.36-0.28-0.29-0.26-0.24-0.31-0.22-0.18-0.12-0.16-0.04-0.04-0.04
Shares Outstanding
19.53M21.41M24.37M24.47M23.82M25.24M25.35M25.55M25.51M26.03M26.32M28.84M28.48M33.44M36.54M46.44M66.14M180.00M187.17M199.01M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
19.53M21.41M24.37M24.47M23.82M25.24M25.35M25.55M25.51M26.03M26.32M28.84M28.48M33.44M36.54M46.44M66.14M180.00M187.17M199.01M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
53.68M49.16M49.16M49.36M49.41M49.49M49.63M49.99M50.15M50.41M50.61M53.92M57.40M57.54M63.21M71.91M121.59M180.00M187.17M199.01M
EBITDA
-13.25M-13.67M-15.73M-16.18M-17.25M-16.27M-18.05M-17.58M-13.15M-13.73M-12.21M-11.48M-14.63M-11.70M-10.21M-6.98M-8.32M-8.18M-8.68M-9.10M
Interest ExpensesInt Expense
0.00M0.35M0.72M1.21M1.27M1.32M1.30M1.29M1.28M1.34M1.12M0.94M0.88M0.73M0.35M0.09M0.01M0.04M

Rani Therapeutics Holdings Income Statement API

Pull Rani Therapeutics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RANI&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY